[{"id":14090,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/sensebiotek\/","name":"sensebiotek","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/Sensebiotek.png","alt":""},"title":"SenseBioTek","postMeta":[],"author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 20, 2025","dateGMT":"2025-12-20 16:52:34","modifiedDate":"2025-12-30 18:26:50","modifiedDateGMT":"2025-12-30 17:26:50","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":30},"status":"publish","excerpt":"SenseBioTek is a healthtech company focused on the development of non-invasive screening solutions for early disease detection, based on the analysis of body odor. The company addresses major unmet medical needs by enabling faster, more objective, and more accessible diagnostic pathways."},{"id":14080,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/cureety\/","name":"cureety","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/Cureety-1.png","alt":""},"title":"Cureety","postMeta":[],"author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 20, 2025","dateGMT":"2025-12-20 16:31:24","modifiedDate":"2025-12-30 17:51:55","modifiedDateGMT":"2025-12-30 16:51:55","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":2,"sec":7},"status":"publish","excerpt":"Cureety is a French digital health company founded in 2018, providing a CE-marked digital medical device that structures, coordinates, and secures outpatient oncology care. Cureety enables proactive follow-up of patients across all cancer treatments while optimizing clinical workflows for multidisciplinary care teams."},{"id":14068,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/e-scopics\/","name":"e-scopics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/Logo-site-JPM-2026-2.png","alt":""},"title":"E-Scopics","postMeta":[],"author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 20, 2025","dateGMT":"2025-12-20 16:07:37","modifiedDate":"2025-12-30 17:29:42","modifiedDateGMT":"2025-12-30 16:29:42","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/medtech\/\" rel=\"category tag\">Medtech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":4},"status":"publish","excerpt":"E-Scopics is disrupting the $8B ultrasound market by dematerializing high-end imaging into a scalable, cloud-based platform."},{"id":13911,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/dentons\/","name":"dentons","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/Logo-site-JPM-2026-1.png","alt":""},"title":"Dentons","postMeta":[],"author":{"name":"lzaim","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/lzaim\/"},"date":"D\u00e9c 9, 2025","dateGMT":"2025-12-09 16:16:02","modifiedDate":"2025-12-10 16:31:39","modifiedDateGMT":"2025-12-10 15:31:39","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/consultant-service-firm\/\" rel=\"category tag\">Consultant\/service firm<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/consultant-service-firm\/\" rel=\"category tag\">Consultant\/service firm<\/a> <a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":0},"status":"publish","excerpt":"Dentons is a global law firm supporting life sciences organizations worldwide.\nDentons is uniquely positioned to support the life sciences sector with a combination of global reach, deep industry expertise, and an unwavering focus on client outcomes. As the largest global law firm, Dentons delivers exceptional legal services through more than 12,000 professionals in 160+ locations across 80 countries, ensuring clients receive support wherever their business operates."},{"id":13867,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/bird-bird\/","name":"bird-bird","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/fichier-logo-sites-2025-12-08T093006.188.png","alt":""},"title":"Bird & Bird","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"D\u00e9c 8, 2025","dateGMT":"2025-12-08 20:18:46","modifiedDate":"2025-12-08 21:18:46","modifiedDateGMT":"2025-12-08 20:18:46","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":41},"status":"publish","excerpt":"Bird & Bird is a truly international firm, organised around its clients, with 1,700 lawyers\u00a0worldwide and a global network spanning 34 offices in 24 countries. With 280+ experts worldwide & a wealth of experience working with life sciences companies & regulatory bodies, Bird & Bird is one of the leading Life Sciences & Healthcare law firm advising clients on their most strategic projects and complex legal challenges."},{"id":13719,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/voison-consulting\/","name":"voison-consulting","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/fichier-logo-sites-2025-12-01T132455.388.png","alt":""},"title":"Voisin Consulting Life Sciences","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"D\u00e9c 1, 2025","dateGMT":"2025-12-01 18:32:04","modifiedDate":"2025-12-08 20:40:07","modifiedDateGMT":"2025-12-08 19:40:07","commentCount":"2","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":0},"status":"publish","excerpt":"Voisin Consulting Life Sciences (VCLS) is a global consulting firm dedicated to guiding biotech, pharma, and medtech companies through the complex journey of bringing health innovations to market. Its mission is to support Life Science developers from early research through clinical development, regulatory approval, and patient access. With multidisciplinary teams across Europe, North America, and Asia, VCLS combines scientific, regulatory, and commercial expertise to accelerate the development of innovative health technologies."},{"id":13692,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/ceres-brain\/","name":"ceres-brain","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/fichier-logo-sites-2025-12-01T133536.403.png","alt":""},"title":"Ceres Brain Therapeutics","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"D\u00e9c 1, 2025","dateGMT":"2025-12-01 18:16:30","modifiedDate":"2025-12-04 16:48:32","modifiedDateGMT":"2025-12-04 15:48:32","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":36},"status":"publish","excerpt":"Ceres Brain Therapeutics is a clinical stage biotech company developing innovative therapeutics to rescue neurons and treat neurological diseases such as Amyotrophic Lateral Sclerosis (ALS) and Creatine Transporter Deficiency (CTD)."},{"id":13683,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/algo-therapeutics\/","name":"algo-therapeutics","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/fichier-logo-sites-2025-12-01T113230.913.png","alt":""},"title":"Apikal Therapeutics","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"D\u00e9c 1, 2025","dateGMT":"2025-12-01 15:35:22","modifiedDate":"2025-12-05 17:11:20","modifiedDateGMT":"2025-12-05 16:11:20","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":8},"status":"publish","excerpt":"Founded by leading scientists and supported by Home Biosciences, Apikal Therapeutics is developing ST420, a first-in-class, disease-modifying therapy for endometriosis, a condition affecting ~190 million women worldwide and lacking effective long-term treatments. ST420 is a novel, proprietary PIK3CA inhibitor with a unique safety profile: it acts on both wild-type and mutant PIK3CA without triggering the hyperglycemia typically induced by other inhibitors. Strong preclinical proof-of-concept demonstrates efficacy, sustained PI3K\/AKT pathway inhibition, favorable ADME\/Tox, controlled glycemia, and robust data reproduced across independent CROs. The company benefits from a seasoned executive team with deep pharma, clinical, and regulatory experience."},{"id":13671,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/neuroclues\/","name":"neuroclues","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/12\/fichier-logo-sites-2025-12-01T095732.999.png","alt":""},"title":"neuroClues","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"D\u00e9c 1, 2025","dateGMT":"2025-12-01 15:02:17","modifiedDate":"2025-12-04 16:50:06","modifiedDateGMT":"2025-12-04 15:50:06","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":50},"status":"publish","excerpt":"NeuroClues is a BrainTech aiming to become the brain\u2019s stethoscope while revolutionizing the identification and follow-up of neurological disorders like Parkinson's & Alzheimer's. Using deep-learning-driven eye-tracking technology, it provide objective, quick and non-invasive physiological biomarkers in a blink that supports clinicians in critical care for their patients with brain health issues."},{"id":13644,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/stromacare-2\/","name":"stromacare-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/11\/fichier-logo-sites-2025-11-28T152821.494.png","alt":""},"title":"Stromacare","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"Nov 28, 2025","dateGMT":"2025-11-28 20:24:34","modifiedDate":"2025-11-28 21:29:20","modifiedDateGMT":"2025-11-28 20:29:20","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":37},"status":"publish","excerpt":"StromaCare aims to develop therapeutics that make the stroma \u2018permeable\u2019 to immune cells and other molecules of interest, to eliminate the cancer."},{"id":13501,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/biper-therapeutics-2\/","name":"biper-therapeutics-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/11\/fichier-logo-sites-2025-11-25T154830.998.png","alt":""},"title":"BiPER Therapeutics","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"Nov 25, 2025","dateGMT":"2025-11-25 20:49:57","modifiedDate":"2026-02-09 16:51:34","modifiedDateGMT":"2026-02-09 15:51:34","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":54},"status":"publish","excerpt":"BiPER Therapeutics opens a new therapeutic pathway in the treatment of cancers and life-threatening diseases. Their team is also developing a pipeline of therapeutics in indications with large market potential and high unmet medical needs through their R&D platform of cellular stress modulation. They aim at quickly expanding worldwide to extend their company activities and connect with new investors."},{"id":13487,"link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/lifen\/","name":"lifen","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/wp-content\/uploads\/sites\/1470\/2025\/11\/fichier-logo-sites-2025-11-25T150944.762.png","alt":""},"title":"Lifen","postMeta":[],"author":{"name":"bsaintleger","link":"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/author\/bsaintleger\/"},"date":"Nov 25, 2025","dateGMT":"2025-11-25 20:08:49","modifiedDate":"2025-12-05 20:23:02","modifiedDateGMT":"2025-12-05 19:23:02","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/french-corner-at-jp-morgan-week\/category\/digital-health\/\" rel=\"category tag\">Digital Health<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":14},"status":"publish","excerpt":"Lifen, founded in 2015, supports healthcare professionals through developing AI solutions to securely share medical data. The company offers innovative solutions and services that help each caregiver to make informed decisions through intelligent use of health data. Its tools, like Lifen Documents, automate the transmission and integration of patient records. This solution allows lower mailing costs, saves time, and ensures successful delivery of reports. Lifen has been working with healthcare professionals to meet the challenge of digital healthcare, thanks to expertise in artificial intelligence coupled with an obsession with impact on the ground. Partnering with 800 hospitals and 20,000 healthcare professionals, Lifen enhances care coordination and accelerates clinical research."}]